Eulerpool Terminal
The edge that pays for itself.
Current Innate Pharma forecasts and price targets in July 2026
Ø Analyst Price Targets
6.27 EUR
+295.03 %
Median
6.27 EUR
+295.03 %
Max
6.51 EUR
Min
6.16 EUR
Last Price
1.59 EUR
Buy
7
Hold
1
Sell
0
The average target price for Innate Pharma is 6.27 EUR. (+295.03 % above the current price)
The median price target of Innate Pharma is 6.27 EUR.
Stock analysts from many renowned investment banks are closely examining the Innate Pharma stock. They conclude their professional Innate Pharma stock analyses with a clear recommendation for the Innate Pharma stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-02-01 | 7 | 1 | 0 | 6.27 EUR |
| 2026-01-01 | 7 | 2 | 0 | 6.27 EUR |
| 2025-12-01 | 7 | 2 | 0 | 4.99 EUR |
| 2025-12-01 | 7 | 2 | 0 | 4.99 EUR |
| 2025-11-01 | 7 | 2 | 0 | 4.94 EUR |
| 2025-11-01 | 7 | 2 | 0 | 5.46 EUR |
Innate Pharma Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Innate Pharma in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2026e | 20.00 M EUR | -32.00 M EUR | -0.35 EUR |
| 2027e | 32.00 M EUR | -39.00 M EUR | -0.43 EUR |
| 2028e | 51.00 M EUR | -53.00 M EUR | -0.58 EUR |